In first Zantac trial, GSK and Boehringer Ingelheim gain key victory

In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez that the heartburn drug caused her colon cancer.